Biodegradable Acoustic Targeting for Ultrasound-Supported Gene Therapy (BATUS) in Glioblastoma.
Overview
and 6 other authors
Ben Bykov8, Claire Hao8, Amir Manbachi8,9, Nicholas Theodore8, Joshua C. Doloff9,10,11, Thanh D. Nguyen1,3,4- Polymer Program Institute of Materials Science University of Connecticut Storrs Connecticut USA
- Department of Pharmaceutical Biotechnology Faculty of Pharmacy Izmir Katip Celebi University Izmir Turkey
- Department of Biomedical Engineering University of Connecticut Storrs Connecticut USA
- Department of Mechanical Engineering University of Connecticut Storrs Connecticut USA
- Center for Clean Energy Engineering University of Connecticut Storrs CT USA
- Ege University Vaccine Development Application and Research Center Izmir Turkey
- Department of Pharmaceutical Biotechnology Faculty of Pharmacy Ege University Izmir Turkey
- Department of Neurosurgery Johns Hopkins School of Medicine Baltimore Maryland USA
- Department of Biomedical Engineering Johns Hopkins School of Medicine Baltimore Maryland USA
- Department of Materials Science and Engineering Johns Hopkins University Baltimore Maryland USA
- Department of Oncology Division of Cancer Immunology Sidney‐Kimmel Comprehensive Cancer Center Bloomberg∼Kimmel Institute for Cancer Immunotherapy Johns Hopkins University Baltimore Maryland USA
Abstract
Glioblastoma (GBM) remains one of the most challenging brain malignancies due to the restrictive nature of the blood–brain barrier (BBB), which severely limits effective drug and gene delivery. To overcome this, we introduce Biodegradable Acoustic Targeting for Ultrasound‐Supported Gene Therapy (BATUS), a modular platform that enables safe, repeated, and targeted gene delivery to the brain. BATUS integrates an implantable, fully biodegradable glycine‐based ultrasound (US) transducer, surgically placed via craniotomy for precise BBB opening, along with customizable peptide‐targeted liposomal gene carriers. This system combines US‐mediated transient BBB disruption with ligand‐directed cellular targeting to enable efficient delivery across both vascular and cellular barriers. As a proof‐of‐concept, BATUS was evaluated using tLyp1‐functionalized liposomes carrying PD‐L1‐targeting siRNA for GBM immunotherapy: in vitro evaluations confirmed efficient siRNA entrapment, stability, and specific cellular uptake, while in vivo studies in orthotopic GL261 GBM mouse models showed enhanced BBB permeability, significant PD‐L1 silencing, reduced tumor growth, and prolonged survival. Crucially, BATUS exhibited a favorable safety profile, with no detectable local or systemic toxicity in animal models. By providing a modular framework where targeting ligands and genetic cargo are easily adaptable, BATUS is established as a strategy for precision gene delivery across the BBB, as demonstrated here for GBM.
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper links to its data, not to its authors' code: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Datasets cited
- doi:10.5061/
dryad.p8cz8wb6h , at Dryad; found in DataCite
Data Availability Statement
The main data supporting the results of this study are available within the paper and its Supplementary Information. The raw data is also published in the DRYAD. The remaining raw and analyzed datasets from the study are available for research purposes upon reasonable request from the corresponding author. Source data were provided in this study.
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 27 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 26 authors, 5 keywords, 11 MeSH terms, 3 funders, 74 references.
Cite
This paper
Erel‐Akbaba, G., Park, J., Duhoon, A., Nguyen, C. T. G., Bhaskar, N., Karan, S. K., Akbaba, H., Singh, P., Tran, T. B. T., Zhu, Y., Li, Z., Muhammad, I., Zhang, X., Truong, H. Q., Davidar, A. D., Schmitzer, E., Vattipally, V. N., Lopez, A. F., Kramer, P., . . . Nguyen, T. D. (2026). Biodegradable Acoustic Targeting for Ultrasound-Supported Gene Therapy (BATUS) in Glioblastoma. Advanced science (Weinheim, Baden-Wurttemberg, Germany), 13(53), e76336. https://
BibTeX
@article{erelakbaba2026b
author = {Erel‐Akbaba, Gulsah and Park, Jinyoung and Duhoon, Achal and Nguyen, Cao Thuy Giang and Bhaskar, Nitu and Karan, Sumanta Kumar and Akbaba, Hasan and Singh, Parbeen and Tran, Thi Bao Tram and Zhu, Yuhui and Li, Zhiming and Muhammad, I'jaaz and Zhang, Xiaojun and Truong, Hoang Quan and Davidar, A. Daniel and Schmitzer, Elizabeth and Vattipally, Vikas N. and Lopez, Angelica F. and Kramer, Patrick and Quiroz, Victor M. and Bykov, Ben and Hao, Claire and Manbachi, Amir and Theodore, Nicholas and Doloff, Joshua C. and Nguyen, Thanh D.},
title = {{Biodegradable Acoustic Targeting for Ultrasound-Supported Gene Therapy (BATUS) in Glioblastoma}},
journal = {Advanced science (Weinheim, Baden-Wurttemberg, Germany)},
year = {2026},
month = jun,
volume = {13},
number = {53},
pages = {e76336},
publisher = {Wiley},
issn = {2198-3844},
doi = {10.1002/
url = {https://
pmid = {42371791},
pmcid = {PMC13336871}
}
RIS
TY - JOUR
AU - Erel‐Akbaba, Gulsah
AU - Park, Jinyoung
AU - Duhoon, Achal
AU - Nguyen, Cao Thuy Giang
AU - Bhaskar, Nitu
AU - Karan, Sumanta Kumar
AU - Akbaba, Hasan
AU - Singh, Parbeen
AU - Tran, Thi Bao Tram
AU - Zhu, Yuhui
AU - Li, Zhiming
AU - Muhammad, I'jaaz
AU - Zhang, Xiaojun
AU - Truong, Hoang Quan
AU - Davidar, A. Daniel
AU - Schmitzer, Elizabeth
AU - Vattipally, Vikas N.
AU - Lopez, Angelica F.
AU - Kramer, Patrick
AU - Quiroz, Victor M.
AU - Bykov, Ben
AU - Hao, Claire
AU - Manbachi, Amir
AU - Theodore, Nicholas
AU - Doloff, Joshua C.
AU - Nguyen, Thanh D.
TI - Biodegradable Acoustic Targeting for Ultrasound-Supported Gene Therapy (BATUS) in Glioblastoma
T2 - Advanced science (Weinheim, Baden-Wurttemberg, Germany)
J2 - Adv Sci (Weinh)
PY - 2026
DA - 2026/
VL - 13
IS - 53
SP - e76336
SN - 2198-3844
PB - Wiley
DO - 10.1002/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1002/
"type": "article-journal",
"title": "Biodegradable Acoustic Targeting for Ultrasound-Supported Gene Therapy (BATUS) in Glioblastoma",
"container-title": "Advanced science (Weinheim, Baden-Wurttemberg, Germany)",
"author": [
{
"family": "Erel‐Akbaba",
"given": "Gulsah"
},
{
"family": "Park",
"given": "Jinyoung"
},
{
"family": "Duhoon",
"given": "Achal"
},
{
"family": "Nguyen",
"given": "Cao Thuy Giang"
},
{
"family": "Bhaskar",
"given": "Nitu"
},
{
"family": "Karan",
"given": "Sumanta Kumar"
},
{
"family": "Akbaba",
"given": "Hasan"
},
{
"family": "Singh",
"given": "Parbeen"
},
{
"family": "Tran",
"given": "Thi Bao Tram"
},
{
"family": "Zhu",
"given": "Yuhui"
},
{
"family": "Li",
"given": "Zhiming"
},
{
"family": "Muhammad",
"given": "I'jaaz"
},
{
"family": "Zhang",
"given": "Xiaojun"
},
{
"family": "Truong",
"given": "Hoang Quan"
},
{
"family": "Davidar",
"given": "A. Daniel"
},
{
"family": "Schmitzer",
"given": "Elizabeth"
},
{
"family": "Vattipally",
"given": "Vikas N."
},
{
"family": "Lopez",
"given": "Angelica F."
},
{
"family": "Kramer",
"given": "Patrick"
},
{
"family": "Quiroz",
"given": "Victor M."
},
{
"family": "Bykov",
"given": "Ben"
},
{
"family": "Hao",
"given": "Claire"
},
{
"family": "Manbachi",
"given": "Amir"
},
{
"family": "Theodore",
"given": "Nicholas"
},
{
"family": "Doloff",
"given": "Joshua C."
},
{
"family": "Nguyen",
"given": "Thanh D."
}
],
"container-title-short":
"volume": "13",
"issue": "53",
"page": "e76336",
"DOI": "10.1002/
"PMID": "42371791",
"PMCID": "PMC13336871",
"ISSN": "2198-3844",
"publisher": "Wiley",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
6,
29
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1038/s41467-026-75092-8
- Video-rate gigapixel ptychography via space-time neural field representations.Journal: Nature communicationsIn common: author Thanh D Nguyen
- [2] doi:10.1038/s41467-026-76725-8
- TogoPhosTAC as a delivery-ready platform for targeted protein dephosphorylation.Journal: Nature communicationsIn common: mouse, cellular / molecular, 2 references
- [3] doi:10.1016/j.crmeth.2026.101427
- Noninvasive focal gene transfer of chemogenetic proteins in the primate brain.Journal: Cell reports methodsIn common: other, 2 references
- [4] doi:10.1158/2159-8290.cd-25-1222 [code]
- PD-1 Blockade-Induced DKK1 Expression by CD8+ T Cells Promotes Blood-Brain Barrier Permeabilization.Journal: Cancer discoveryIn common: other condition, mouse, cellular / molecular, 1 reference
- [5] doi:10.1038/s41467-026-74888-y
- Engineered zwitterion-nanodelivery for precision targeting of brain metastases.Journal: Nature communicationsIn common: other condition, mouse, 1 reference
- [6] doi:10.3390/ijms27156671
- Inflamed Yet Immune-Evasive? A Transcriptomic Meta-Analysis Identifies Conserved Inflammatory, Developmental, and Neuronal Signatures Associated with Polyploid Giant Cancer Cells.Journal: International journal of molecular sciencesIn common: other condition, cellular / molecular, 1 reference
- [7] doi:10.1172/jci.insight.198298
- Development and characterization of triazole-based WDR5 inhibitors for the treatment of glioblastoma.Journal: JCI insightIn common: other condition, mouse, 1 reference
- [8] doi:10.1002/mp.70520
- A new in silico model to precisely design focused ultrasound brain therapies.Journal: Medical physicsIn common: other, 1 reference
- [9] doi:10.3390/toxics14060504
- Molecular Mechanisms of 6PPD and 6PPD-Q Toxicity in Neurodegenerative Diseases: A Network Toxicology and Experimental Validation Study.Journal: ToxicsIn common: other condition, cellular / molecular, 1 reference
- [10] doi:10.1186/s12974-026-03964-3
- Circulating immune profiling reveals impaired monocyte states and trajectories driving immunosuppression in glioblastoma.Journal: Journal of neuroinflammationIn common: other condition, 1 reference
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.
Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
